News|Articles|August 1, 2025
How One Brand Protected Market Share Amid Biosimilar Pressure
Case study on how one mature/late stage biopharmaceutical brand leveraged SamaCare’s insights and intervention platform to decrease administrative related discontinuations of their drug and maintain market share during a biosimilar release.
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement
3
Pharmaceutical Executive Daily: FDA Grants Traditional Approval to Novartis's Fabhalta
4
Eli Lilly to Acquire AtaiBeckley for $2.8 Billion
5